南美超级胎牛血清999尝鲜特惠转染试剂低至5折基质胶阶梯特惠积分商城,好礼送不停南美超级胎牛血清999尝鲜特惠转染试剂低至5折基质胶阶梯特惠积分商城,好礼送不停

Gal-9/Tim-3信号:PTEN缺失型胶质母细胞瘤的可行治疗靶点

Interrogating glioma-M2 macrophage interactions identifies Gal-9/Tim-3 as a viable target against PTEN-null glioblastoma

Xiangrong Ni, Weichi Wu, Xiaoqiang Sun, Junxiao Ma, Zhihui Yu, Xinwei He, Jinyu Cheng, Pengfei Xu, Haoxian Liu, Tengze Shang, Shaoyan Xi, Jing Wang, Ji Zhang, Zhongping Chen

Journal:Science Advances

IF:14.96

DOI:10.1126/sciadv.abl5165

PMID:35857445

Published:2022-07-08

research field:分子生物学毒理学肺纤维化药理学信号转导细胞衰老表观遗传学

Abstract

Genomic alteration can reshape tumor microenvironment to drive tumor malignancy. However, how PTEN deficiency influences microenvironment-mediated cell-cell interactions in glioblastoma (GBM) remains unclear. Here, we show that PTEN deficiency induces a symbiotic glioma-M2 macrophage interaction to support glioma progression. Mechanistically, PTEN-deficient GBM cells secrete high levels of galectin-9 (Gal-9) via the AKT-GSK3β-IRF1 pathway. The secreted Gal-9 drives macrophage M2 polarization by activating its receptor Tim-3 and downstream pathways in macrophages. These macrophages, in turn, secrete VEGFA to stimulate angiogenesis and support glioma growth. Furthermore, enhanced Gal-9/Tim-3 expression predicts poor outcome in glioma patients. In GBM models, blockade of Gal-9/Tim-3 signaling inhibits macrophage M2 polarization and suppresses tumor growth. Moreover, α-lactose attenuates glioma angiogenesis by down-regulating macrophage-derived VEGFA, providing a novel antivascularization strategy. Therefore, our study suggests that blockade of Gal-9/Tim-3 signaling is effective to impair glioma progression by inhibiting macrophage M2 polarization, specifically for PTEN-null GBM.

本文使用的Yeasen产品

产品应用
购物车
客服
转染试用